Hyperbaric oxygen therapy may be effective to improve hypoxemia in patients with severe COVID-2019 pneumonia: two case reports

Two male patients ages 57 and 64 years old were treated with a 1-week course of hyperbaric oxygen therapy at 1.5 ATA (60 minutes per session)

Shortness of breath subsided immediately with both patients after the first hyperbaric session and resolved by the end of the 7 days. More notably, neither patient became critically ill and the lung CT scans showed remarkable improvement in lung pathology.

The authors of this study concluded this report by suggesting that “hyperbaric oxygen therapy may promptly improve the progressive hypoxemia of patients with COVID-2019 pneumonia” <view study>